October 28th 2024
This trial will assess an individualized neoantigen therapy plus Keytruda in some patients with non-small cell lung cancer.
October 28th 2024
October 27th 2024
October 28th 2024
October 25th 2024
October 24th 2024
October 23rd 2024
October 27th 2024
October 23rd 2024
October 13th 2024
October 6th 2024
October 26th 2024
October 14th 2024
October 12th 2024
October 11th 2024